Medtronic InFuse New Technology Add-On Payment Hinges On FDA Approval

Medtronic's InFuse bone graft/LT-Cage lumbar tapered fusion device will be the first product to receive a new technology "add-on" payment under the inpatient prospective payment system (IPPS), provided FDA grants the device PMA approval before publication of the FY 2003 final rule